Anaplastic Large Cell Lymphoma Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • brentuximab vedotin
  • Anaheim, California
  • +18 more
2022-04-01
Apr 1, 2022
T
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
2021-10-04
Oct 4, 2021
N
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
2020-10-14
Oct 14, 2020
M
Completed
  • B-cell Follicular Lymphoma
  • +12 more
  • Scottsdale, Arizona
  • +9 more
2019-02-15
Feb 15, 2019
U
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +4 more
  • Atlanta, Georgia
  • +2 more
2018-07-25
Jul 25, 2018
M
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +45 more
  • anti-endosialin/TEM1 monoclonal antibody MORAb-004
  • +2 more
  • Birmingham, Alabama
  • +19 more
2016-01-07
Jan 7, 2016
N
Terminated
  • Anaplastic Large Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2014-05-29
May 29, 2014
N
Completed
  • Anaplastic Large Cell Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2014-05-21
May 21, 2014
N
Completed
  • Anaplastic Large Cell Lymphoma
  • +5 more
  • Chicago, Illinois
  • +1 more
2014-05-07
May 7, 2014
X
Completed
  • Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • XmAb2513
  • Chicago, Illinois
  • +3 more
2014-04-18
Apr 18, 2014
N
Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +61 more
  • bevacizumab
  • cediranib maleate
  • Houston, Texas
    M D Anderson Cancer Center
2014-02-14
Feb 14, 2014